Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ramon Fontova-Garrofé"'
Autor:
Samantha Rodríguez-Muguruza, Antonio Altuna-Coy, Verónica Arreaza-Gil, Marina Mendieta-Homs, Sonia Castro-Oreiro, Maria José Poveda-Elices, Nuria del Castillo-Piñol, Ramon Fontova-Garrofé, Matilde R. Chacón
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveThere is an urgent need for novel biomarkers to improve the early diagnosis of rheumatoid arthritis (ERA). Current serum biomarkers used in the management of ERA, including rheumatoid factor and anti-cyclic citrullinated peptide (ACPA), show
Externí odkaz:
https://doaj.org/article/1a6301f31e314a8ca465f815532f24da
Autor:
Samantha Rodríguez-Muguruza, Antonio Altuna-Coy, Sonia Castro-Oreiro, Maria José Poveda-Elices, Ramon Fontova-Garrofé, Matilde R. Chacón
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe etiology of rheumatoid arthritis (RA) remains poorly understood. Early and accurate diagnosis still difficult to achieve. Inflammatory related molecules released into the circulation such cytokines and exosome-derived microRNAs (exomiRN
Externí odkaz:
https://doaj.org/article/948a49520cfe4350b4a002ad6f715e26
Autor:
Paloma Vela Casasempere, Vicente Javier Clemente-Suárez, Rodriguez Heredia Jose Manuel, JOSE RAMON MANEIRO, Estefania Moreno Ruzafa, Raimon Sanmarti, Juan Gomez-Reino, Carlos Alonso-Villaverde, Esperanza Naredo, Ramon Fontova Garrofé, Maria Galindo, Rubén Queiro, Carlos Marras, Mireia Alcalde
Publikováno v:
Annals of the Rheumatic Diseases. 71:1861-1864
ObjectiveTo compare the effectiveness of switching to rituximab (RTX) with switching to alternative tumour necrosis factor (TNF) antagonists in patients with rheumatoid arthritis (RA) failing on TNF antagonists.MethodsA multicentre prospective 3-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7780c07bb488c31281045cd5492177d4
https://doi.org/10.1136/annrheumdis-2012-201324
https://doi.org/10.1136/annrheumdis-2012-201324